
Thane Noble Pharma Llp
Founded in 2018 and headquartered in Maharashtra, India.
Founded in 2018 and headquartered in Maharashtra, India.
Thane Noble Pharma Llp (TNPL) is 7 Year, 1 Month old Limited Liability Partnership 27 March 2018. Its registered office is in Latur, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Latur, Maharashtra, India
+91-XXXXXXXXXX
AAM-3128
27 Mar 2018
31 Mar 2023
Roc-Mumbai
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deepak Belure ![]() | Designated Partner | 27-Mar-2018 | Current |
Sachidanand Belure ![]() | Designated Partner | 27-Mar-2018 | Current |
Enhance accessibility to Thane Noble Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Thane Noble Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Deepak Belure and Sachidanand Belure are mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Thane Noble Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Thane Noble Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thane Noble Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Thane Noble Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Mumbai.
Deepak Somnathappa Belure was appointed as a Designated Partner was appointed as a Designated Partner on 27 Mar 2018 & has been associated with this company since 7 years 1 month .
Sachidanand Shivraj Belure was appointed as a Designated Partner was appointed as a Designated Partner on 27 Mar 2018 & has been associated with this company since 7 years 1 month .
Thane Noble Pharma Llp was registered on 27 Mar 2018 with RoC-Mumbai & aged 7 years 1 month as per MCA records.
Thane Noble Pharma Llp was incorporated on 27 Mar 2018.
The Obligation of Contribution of Thane Noble Pharma Llp is ₹ 0.10 M.
Currently 2 partners are associated with Thane Noble Pharma Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Thane Noble Pharma Llp is Gadighar Road Tq., Dist. Na, Latur, Maharashtra, India, 413512.
The Limited Liability Partnership Identification Number (LLPIN) of Thane Noble Pharma Llp is AAM-3128.
The most recent Balance Sheet for Thane Noble Pharma Llp was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.